サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1679363

北米と欧州の静脈内輸液ポンプ市場規模、シェア、動向分析レポート：製品別、適応疾患別、最終用途別、地域別、セグメント別予測、2025年～2030年

North America And Europe Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report By Product, By Disease Indication, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
北米と欧州の静脈内輸液ポンプ市場規模、シェア、動向分析レポート：製品別、適応疾患別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年02月26日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場規模と動向

北米と欧州の静脈内輸液ポンプ市場規模は、2024年に44億5,000万米ドルとなり、2025～2030年にかけてCAGR 8.10％で成長すると予測されています。

この成長は、呼吸器疾患、脳卒中、糖尿病、がん、心血管疾患などの慢性疾患の有病率の増加に起因しており、心血管疾患は欧州と北米における主要な死因です。例えば、米国保健福祉省によると、米国では推定1億2,900万人が少なくとも1つの主要な慢性疾患を抱えています。静脈内注入ポンプは、放射線療法や化学療法による患者の治療中に、栄養素や薬剤を制御、調整し、間違いのないように送達します。これらのポンプを使用することで、投与中のミスを減らすことができます。投薬ミスは最も一般的なタイプのミスであり、慢性疾患の患者を扱っている間は不注意に扱うことはできません。

より安全で、より効率的で、標準化された先進的送達システムが必要とされています。スマート輸液ポンプや次世代静脈内ポンプの導入は、ポンプ市場全体に大きな成長機会をもたらしています。スマートポンプは、薬剤ライブラリーの存在により薬剤投与ミスを減少させ、安全な薬剤投与を確保することを目的としたコンピューターソフトウェアシステムを組み込んだ輸液デバイスです。例えば、2024年4月、カナダのMackenzie Healthは、医療システムとして初めてBD Alaris EMR相互運用性を導入し、輸液ポンプと電子カルテ（EMR）の双方向通信を可能にしました。この進歩により、手作業によるプログラミングが不要になり、ワークフローの効率を向上させながら、投薬ミスを大幅に減らすことができます。研究によると、輸液プログラミングに必要なキー入力が86%減少しています。このようなスマート輸液技術は、相互運用可能で自動化された輸液ポンプに対する病院の需要を高め、市場の成長を促進しています。

先進的な輸液ポンプ技術の規制認可は、静脈内輸液ポンプ市場の主要な市場促進要因であり、医療環境における患者の安全性、効率性、接続性を向上させています。例えば、2024年4月、Baxter International Inc.は、Novum IQ輸液プラットフォームを拡大するDose IQ安全ソフトウェアを搭載したNovum IQ大容量輸液ポンプのFDA 510（k）認可を最近取得しました。大容量ポンプとシリンジポンプの両方を含むこの統合システムは、臨床医が複数の医療現場で単一の接続されたプラットフォームを使用することを可能にし、ワークフローの効率を高め、投薬ミスを減らします。病院がスマートで相互運用可能な輸液技術を採用する傾向が強まる中、次世代輸液ポンプの需要は大きく伸びると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 北米と欧州の静脈内輸液ポンプ市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 北米と欧州の静脈内輸液ポンプ市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 北米と欧州の静脈内輸液ポンプ市場：製品別、推定・動向分析

  • 北米と欧州の静脈内輸液ポンプ市場：製品ダッシュボード
  • 北米と欧州の静脈内輸液ポンプ市場：製品変動分析
  • 北米と欧州の静脈内輸液ポンプ市場規模と予測と動向分析、製品別、2018～2030年
  • 容積式輸液ポンプ
  • シリンジ輸液ポンプ
  • 携帯型輸液ポンプ
  • 患者自己管理鎮痛輸液ポンプ
  • 埋め込み型輸液ポンプ
  • その他

第5章 北米と欧州の静脈内輸液ポンプ市場：疾患適応症別、推定・動向分析

  • 北米と欧州の静脈内輸液ポンプ市場：疾患適応症ダッシュボード
  • 北米と欧州の静脈内輸液ポンプ市場：疾患適応症変動分析
  • 北米と欧州の静脈内輸液ポンプ市場の規模と予測と動向分析、疾患適応症別、2018～2030年
  • 化学療法
  • 糖尿病
  • 消化器内科
  • 鎮痛/疼痛管理
  • 小児科・新生児科
  • 血液学
  • その他

第6章 北米と欧州の静脈内輸液ポンプ市場：最終用途別、推定・動向分析

  • 北米と欧州の静脈内輸液ポンプ市場：最終用途ダッシュボード
  • 北米と欧州の静脈内輸液ポンプ市場：最終用途変動分析
  • 北米と欧州の静脈内輸液ポンプ市場の規模と予測と動向分析、最終用途別、2018～2030年
  • 病院
  • 在宅医療
  • その他

第7章 北米と欧州の静脈内輸液ポンプ市場：国、製品、疾患適応症、最終用途による地域別、推定・動向分析

  • 北米と欧州の静脈内輸液ポンプ市場：地域ダッシュボード
  • 市場規模と予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク

第8章 競合情勢

  • 主要メーカーによる最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店とチャネルパートナー一覧
    • 主要企業の市場シェア分析、2024年
    • Baxter
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • ICU Medical, Inc.（Smiths Medical）
    • Micrel Medical Devices SA
    • Boston Scientific Corporation
    • BD
    • Terumo Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Moog Inc.
    • IRadimed Corporation
    • CODAN Companies
    • Arcomed
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America & Europe Intravenous Infusion Pumps Market, by Country, 2018 - 2030 (USD Million)
  • Table 4. North America & Europe Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million) (Volume Unit)
  • Table 5. North America & Europe Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 6. North America & Europe Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7. North America Intravenous Infusion Pumps Market, by Country, 2018 - 2030 (USD Million)
  • Table 8. North America Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 9. North America Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 10. North America Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 11. U.S. Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 12. U.S. Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 13. U.S. Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14. Canada Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 15. Canada Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 16. Canada Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17. Mexico Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 18. Mexico Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 19. Mexico Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20. Europe Intravenous Infusion Pumps Market, by Country, 2018 - 2030 (USD Million)
  • Table 21. Europe Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 22. Europe. Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 23. Europe Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24. Germany Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 25. Germany Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 26. Germany Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27. UK Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 28. UK Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 29. UK Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. France Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 31. France Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 32. France Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33. Italy Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 34. Italy Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 35. Italy Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36. Spain Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 37. Spain Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 38. Spain Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 39. Denmark Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 40. Denmark Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 41. Denmark Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Sweden Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 43. Sweden Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 44. Sweden Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45. Norway Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 46. Norway Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 47. Norway Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48. Participant's Overview
  • Table 49. Financial Performance
  • Table 50. Product Benchmarking
  • Table 51. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Market Formulation & Validation
  • Fig. 5 Intravenous Infusion Pumps Market, Market Segmentation
  • Fig. 6 Market Driver Analysis (Current & Future Impact)
  • Fig. 7 Market Restraint Analysis (Current & Future Impact)
  • Fig. 8 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Regional Marketplace: Key Takeaways
  • Fig. 13 North America & Europe Intravenous Infusion Pumps Market, for Ultrasound, 2018 - 2030 (USD Million)
  • Fig. 14 North America & Europe Intravenous Infusion Pumps Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 North America & Europe Intravenous Infusion Pumps Market, for Volumetric Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 16 North America & Europe Intravenous Infusion Pumps Market, for Syringe Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 17 North America & Europe Intravenous Infusion Pumps Market, for Ambulatory Infusion Pumps, 2018 - 2030 (USD Million) (Procedure Volume)
  • Fig. 18 North America & Europe Intravenous Infusion Pumps Market, for Patient-Controlled Analgesia Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 19 North America & Europe Intravenous Infusion Pumps Market, for Implantable Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 20 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 21 North America & Europe Intravenous Infusion Pumps Market, for Disease Indication, 2018 - 2030 (USD Million)
  • Fig. 22 North America & Europe Intravenous Infusion Pumps Market, for Chemotherapy, 2018 - 2030 (USD Million)
  • Fig. 23 North America & Europe Intravenous Infusion Pumps Market, for Diabetes, 2018 - 2030 (USD Million)
  • Fig. 24 North America & Europe Intravenous Infusion Pumps Market, for Gastroenterology, 2018 - 2030 (USD Million)
  • Fig. 25 North America & Europe Intravenous Infusion Pumps Market, for Analgesia/Pain Management, 2018 - 2030 (USD Million)
  • Fig. 26 North America & Europe Intravenous Infusion Pumps Market, for Pediatrics/Neonatology, 2018 - 2030 (USD Million)
  • Fig. 27 North America & Europe Intravenous Infusion Pumps Market, for Hematology, 2018 - 2030 (USD Million)
  • Fig. 28 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 North America & Europe Intravenous Infusion Pumps Market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 30 North America & Europe Intravenous Infusion Pumps Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 31 North America & Europe Intravenous Infusion Pumps Market, for Homecare, 2018 - 2030 (USD Million)
  • Fig. 32 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Outlook, 2024 & 2030
  • Fig. 34 North America Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 39 UK Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 40 France Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-528-7

Market Size & Trends:

The North America and Europe intravenous infusion pumps market size was valued at USD 4.45 billion in 2024 and is projected to grow at a CAGR of 8.10% from 2025 to 2030. This growth is attributed to the increase in the prevalence of chronic diseases such as respiratory diseases, stroke, diabetes, cancer, and cardiovascular diseases, wherein cardiovascular disease is the major cause of death in Europe and North America. For instance, according to the U.S. Department of Health and Human Services, an estimated 129 million people in the US have at least one major chronic disease. Intravenous infusion pumps ensure controlled, regulated, & error-free delivery of nutrients and medications while treating patients via radiation therapy or chemotherapy, as these are very complex processes and require precise dosages of medication. The use of these pumps helps in reducing errors during administration, as medication errors are the most common types of errors and cannot be taken carelessly while handling patients with chronic diseases.

There is a need for advanced delivery systems that are safer, more efficient, and standardized. The introduction of smart infusion pumps or next-generation intravenous pumps is imparting greater growth opportunities for the overall pump market. Smart pumps are infusion devices that are embedded with a computer software system aimed at decreasing drug dosing errors through the presence of drug libraries, ensuring safe medication administration. For instance, in April 2024, Mackenzie Health in Canada became the first healthcare system to implement BD Alaris EMR Interoperability, enabling two-way communication between IV infusion pumps and electronic medical records (EMRs). This advancement eliminates the need for manual programming, significantly reducing medication administration errors while improving workflow efficiency. Studies show an 86% reduction in keystrokes needed for infusion programming. Such smart infusion technologies are driving market growth by increasing hospital demand for interoperable and automated IV pumps.

Regulatory approvals of advanced infusion pump technologies are a key market driver for the intravenous infusion pump market, improving patient safety, efficiency, and connectivity in healthcare settings. For instance, in April 2024, Baxter International Inc. recently received FDA 510(k) clearance for its Novum IQ large volume infusion pump with Dose IQ Safety Software, expanding its Novum IQ Infusion Platform. This integrated system, which includes both large volume and syringe pumps, allows clinicians to use a single, connected platform across multiple care settings, enhancing workflow efficiency and reducing medication errors. As hospitals increasingly adopt smart, interoperable infusion technologies, demand for next-generation IV pumps is expected to grow significantly.

North America And Europe Intravenous Infusion Pumps Market Report Segmentation

This report forecasts revenue growth at regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the North America and Europe intravenous infusion pumps market report on the basis of product, disease indication, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Implantable Infusion Pumps
  • Others
  • Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Homecare
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Disease Indication
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. Disease Indication Segment
    • 2.2.3. End-use Segment
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. North America and Europe Intravenous Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of chronic diseases
      • 3.2.1.2. Technological advancements in infusion pumps
      • 3.2.1.3. Rising demand for ambulatory infusion pumps
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of reimbursement
      • 3.2.2.2. Increasing product recalls
  • 3.3. North America and Europe Intravenous Infusion Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. North America and Europe Intravenous Infusion Pumps Market: Product Estimates & Trend Analysis

  • 4.1. North America and Europe Intravenous Infusion Pumps Market: Product Dashboard
  • 4.2. North America and Europe Intravenous Infusion Pumps Market: Product Movement Analysis
  • 4.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Volumetric Infusion Pumps
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Syringe Infusion Pumps
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Ambulatory Infusion Pumps
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Patient-Controlled Analgesia Infusion Pumps
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.8. Implantable Infusion Pumps
    • 4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Estimates & Trend Analysis

  • 5.1. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Dashboard
  • 5.2. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
  • 5.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Diabetes
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Gastroenterology
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Analgesia/Pain Management
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.8. Pediatrics/Neonatology
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.9. Hematology
    • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. North America and Europe Intravenous Infusion Pumps Market: End-use Estimates & Trend Analysis

  • 6.1. North America and Europe Intravenous Infusion Pumps Market: End-use Dashboard
  • 6.2. North America and Europe Intravenous Infusion Pumps Market: End-use Movement Analysis
  • 6.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Homecare
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. North America and Europe Intravenous Infusion Pumps Market: Regional Estimates & Trend Analysis by Country, Product, Disease Indication, and End-use

  • 7.1. North America and Europe Intravenous Infusion Pumps Market: Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Baxter
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. End-use benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. B. Braun Melsungen AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. End-use benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Fresenius Kabi AG
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. End-use benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. ICU Medical, Inc. (Smiths Medical)
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. End-use benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Micrel Medical Devices SA
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. End-use benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Boston Scientific Corporation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. End-use benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. BD
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. End-use benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Terumo Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. End-use benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. End-use benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Moog Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. End-use benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. IRadimed Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. End-use benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. CODAN Companies
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. End-use benchmarking
      • 8.3.15.4. Strategic initiatives
    • 8.3.16. Arcomed
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial performance
      • 8.3.16.3. End-use benchmarking
      • 8.3.16.4. Strategic initiatives